Table 1 Demographics of Entire Cohort of FORTE Study Participants
From: Eosinophil and T cell markers predict functional decline in COPD patients
| Â | FORTE Subjects | |
|---|---|---|
| Â | Mean | Std |
N | 148 | Â |
Age at Randomization, years | 65.8 | 7.4 |
Gender, % male | 58.1 | Â |
Smoking HX, pack-years | 57.8 | 29 |
BL Chronic cough, % subjects | 24.5 | Â |
BL StGeo Total Score | 39.3 | 13.1 |
BL Post-BD %Pred FEV1 | 42.5 | 13.7 |
BL Post-BD %Pred FVC | 80.1 | 15.7 |
Bronchodilator response, % changed | 12.7 | 10.4 |
BL %Pred TLC | 118.1 | 16.2 |
BL %Pred RV (meth A) | 180.8 | 48.1 |
BL %Pred DLCO | 37.1 | 12.0 |
DLCO/VA, %Pred | 46.3 | 16.1 |
BL CT Score, %emph | 38.5 | 12.8 |